Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma. - Wikidata - awgldk - TriplyDB

Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.

Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.

http://www.wikidata.org/entity/Q33793577

about

Does IL-17 Respond to the Disordered Lung Microbiome and Contribute to the Neutrophilic Phenotype in Asthma?The microbiome in asthma Biomarkers in the Management of Difficult Asthma Altered Innate Immune Responses in Neutrophils from Patients with Well- and Suboptimally Controlled Asthma The respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?Trans-basement membrane migration of eosinophils induced by LPS-stimulated neutrophils from human peripheral blood in vitro Pathogenic CD4+ T cells in patients with asthma.Microbiota in T-cell homeostasis and inflammatory diseases Microbiome diversity and asthma and allergy risk.The respiratory microbiome and innate immunity in asthma The changing face of asthma and its relation with microbes A comprehensive review of the nasal microbiome in chronic rhinosinusitis (CRS).The Microbiome and the Respiratory Tract Obesity, Asthma, and the Microbiome.Innate and adaptive T cells in asthmatic patients: Relationship to severity and disease mechanisms Airway Microbiota in Severe Asthma and Relationship to Asthma Severity and Phenotypes.Haemophilus influenzae responds to glucocorticoids used in asthma therapy by modulation of biofilm formation and antibiotic resistance High IFN-γ and low SLPI mark severe asthma in mice and humans.The respiratory microbiome in bronchial mucosa and secretions from severe IgE-mediated asthma patients Lung Microbiome Analysis in Steroid-Naїve Asthma Patients by Using Whole Sputum Airway Surfactant Protein D Deficiency in Adults With Severe Asthma The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?The Potential for Emerging Microbiome-Mediated Therapeutics in Asthma.Neutrophilic Inflammation in Asthma and Association with Disease Severity.Advanced Role of Neutrophils in Common Respiratory Diseases The microbiome in allergic disease: Current understanding and future opportunities-2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology.Novel approaches to the management of noneosinophilic asthma.Diagnosis and investigation in the severe asthma clinic.IRF5 distinguishes severe asthma in humans and drives Th1 phenotype and airway hyperreactivity in mice Airway Microbiota and the Implications of Dysbiosis in Asthma.Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Nothing New Under the Sun.The microbiome in asthma.Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.Phenotype-Driven Therapeutics in Severe Asthma.Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma.Eosinophilic and Non-Eosinophilic Asthma.Airway and serum biochemical correlates of refractory neutrophilic asthma.Neutrophilic inflammation in asthma: mechanisms and therapeutic considerations.Decreased FEV1 % in asthmatic adults in Scottish homes with high Environmental Relative Moldiness Index values.Allergen specific immunotherapy enhanced defense against bacteria via TGF-β1-induced CYP27B1 in asthma.

P2860

Q26768646-BAFBC5AB-D87C-47C5-B9DC-9092380D0D5E Q28080434-AC1A9620-FFBD-49A0-A244-7ED6CAE28610 Q28081109-C1836D4D-6B6C-41D8-8C97-C568D03CC7DE Q28395377-B1C7A31C-00DB-4139-83B2-6F0559974115 Q28396321-12E7F209-322D-4173-AAD7-294557A40194 Q28596831-7D637636-593F-4D40-A78E-7D3919B90534 Q30252507-4515A42A-2E57-4237-A9B1-279CAADCFAB7 Q33754038-D09A73BF-9729-45F6-9165-2F27040CEBA1 Q35230090-0759E88F-6B83-47EE-91AF-3EEB9388DEAD Q35430866-DAB35694-1DA5-4188-9084-678D7BA31BD2 Q35594963-B9A6307F-FC3D-4FCB-8CD2-B5A490216C02 Q35824636-40046092-BE57-4171-BF14-C2E4B9DF4F3B Q35829947-A7F2705F-409F-4363-8C3F-90AC5C4C76B3 Q35926923-5BB9A5FD-3809-4A49-AC00-B20C23F205C6 Q35947771-CB5F2D35-71DB-42BC-8124-DBF1C83B73DA Q35989768-0B357BBC-0276-48D6-8786-31616950E4F0 Q36000796-6A17DD3C-BF01-4E8B-8BFE-8EDCCB882FC7 Q36040504-4321BF7D-2136-4508-BF1C-E8F6D4E5BACF Q36254351-4054B00B-77F7-4336-9464-54B5A2F63A6E Q37092477-07513EFC-0C1E-4848-A70D-8C157285849F Q37094632-A69DA447-A6C9-4E0A-A388-708FF0AF6B30 Q37643936-D3269FE7-280B-41AD-A1FB-01BDCB880DDB Q38622649-421C138D-C2D3-4D99-B971-6D65F798D294 Q38645834-092EC273-E257-4788-8C0D-72FDF7B2A99F Q38739370-D311880E-A4E2-46DD-AE71-F70C410BD553 Q38750982-9178F6CE-B960-4905-895A-2231170E88D1 Q38756064-C30FBDAD-B853-4687-989E-08B433D022F6 Q38770013-B42D9B4A-3862-4F6A-BEF1-0CE3726EAA77 Q38780046-18C5C734-09A9-4DFB-A729-3463CF65284B Q38890722-5FD72B9C-50E8-484B-BB58-9878A75F2C5D Q38892965-614F33F3-234D-4619-B12C-96592A866238 Q38949256-571FA99F-5016-43F6-87F8-E1F0943305B6 Q39063083-1D2FB4C1-045C-496F-94BB-D8A96828B441 Q39148802-D431519D-8158-4D3A-9FBB-A5AE45337E37 Q39402899-D4D28726-26A0-4958-8BC9-7F7FF7A06D47 Q40046428-3C5A422D-1B3A-479C-9E04-CBB0369387F3 Q40344650-E4266B13-0AA1-485C-B0EE-BEB5BD5AFD72 Q40423635-A2DCB5BF-B889-4894-9B79-0F7DA4B6756C Q41549678-7E34A72A-FEEB-4BB2-AEF7-2D723B912243 Q41991209-3A7BC222-233F-403B-87E4-0F9D8E130501

P2860

Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.

http://www.wikidata.org/entity/Q33793577

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Potentially pathogenic airway ...... tment resistant severe asthma.

@ast

Potentially pathogenic airway ...... tment resistant severe asthma.

@en

type

label

Potentially pathogenic airway ...... tment resistant severe asthma.

@ast

Potentially pathogenic airway ...... tment resistant severe asthma.

@en

prefLabel

Potentially pathogenic airway ...... tment resistant severe asthma.

@ast

Potentially pathogenic airway ...... tment resistant severe asthma.

@en

P1433

Q33793577-813466EB-9745-4806-AA2D-FB12C5601337

P1476

Q33793577-BE1D1248-6572-4A71-B9D2-8A3580AFCC30

P2093

Q33793577-236AC467-6315-4F35-961C-A66CC5112B63

Q33793577-3C4AAE7D-9724-4C6B-854C-84F68B58C17A

Q33793577-7E06D43E-B5D3-4F86-9AAD-A4DD5C1C6BFC

Q33793577-BC20F5CD-3542-459B-AD84-A8C1434987FC

Q33793577-D32658C2-CA26-413F-B6E7-2BC17A132FDB

Q33793577-D5635511-DADB-4D6E-B32A-FD9027D2F443

Q33793577-FCF29BA0-B6A1-47D0-B0C1-8D3564C0F21E

P2860

Q33793577-093DD378-2EEA-4CF5-8163-405631EFE3D1

Q33793577-099DDA04-09EB-4A04-B441-107BAE08729F

Q33793577-12E349C3-FF5B-423E-AA90-7D77F00F8FE3

Q33793577-170A1A8B-2608-4592-B434-0A078E177EC3

Q33793577-1C723AC7-6B1F-4193-A9F8-72A7ED3440C8

Q33793577-1D094384-7B60-407F-85A2-24751842FA12

Q33793577-1F622C45-A410-4727-9B0F-9C974D8774FB

Q33793577-21ABDA6D-B9C3-443F-9B26-3AA9A93DF9BA

Q33793577-303FC330-27E9-4D44-9227-A3F645539F1F

Q33793577-3526B39C-6DC3-42C7-BC8B-BFAD71174C97

P304

Q33793577-3670B0F8-DD25-4461-B48F-AF46FEA6E2C1

P31

Q33793577-A790D87A-748D-4B7F-99B7-467B2E4F0814

P356

Q33793577-33054EDE-B71C-4114-BD8F-CFAA636BB736

P407

Q33793577-84E7EA6D-5DDE-40AE-9243-639D7EF98DA8

P433

Q33793577-229C5767-B419-43B9-B49F-4E347C1C1CDB

P478

Q33793577-31C25CD4-5C64-4FF0-905B-F5740167E78D

P50

Q33793577-9EE67D1F-C568-4C1E-8FE9-272D98EADCDA

Q33793577-CCC8A5EB-D9E7-48A3-B030-357AF3DDD58D

P577

Q33793577-7517CBC4-7A5B-4218-8FA4-C5C484EE2D3F

P5875

Q33793577-3E6FEC97-A72D-421D-BA66-2AEE721751AB

P698

Q33793577-08FBDD4C-A218-45D3-995D-0420EACAB0E7

P921

Q33793577-DB5997F4-55BA-4BB1-A538-9CCB9D3E8786

P932

Q33793577-315BFE83-AC92-4F6D-8765-7F4C70FA5E94

P356

JOURNAL.PONE.0100645

P1433

P1476

Potentially pathogenic airway ...... tment resistant severe asthma.

@en

P2093

Benjamin J Green

http://www.w3.org/2001/XMLSchema#string

Kenneth D Bruce

http://www.w3.org/2001/XMLSchema#string

Laurie Lau

http://www.w3.org/2001/XMLSchema#string

Mary P Carroll

http://www.w3.org/2001/XMLSchema#string

Peter H Howarth

http://www.w3.org/2001/XMLSchema#string

Surasa Wiriyachaiporn

http://www.w3.org/2001/XMLSchema#string

Valia Kehagia

http://www.w3.org/2001/XMLSchema#string

P2860

Disordered microbial communities in asthmatic airways

Macrolides for chronic asthma

Macrolides for chronic asthma

A novel microbiota stratification system predicts future exacerbations in bronchiectasis

The effects of airway microbiome on corticosteroid responsiveness in asthma

Determining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.

Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma.

Long-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.

Microbiome diversity in the bronchial tracts of patients with chronic obstructive pulmonary disease.

Clarithromycin targets neutrophilic airway inflammation in refractory asthma.

P304

e100645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0100645

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Geraint B Rogers

Christopher L Grainge

P577

2014-06-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263356336

http://www.w3.org/2001/XMLSchema#string

P698

24955983

http://www.w3.org/2001/XMLSchema#string

P921

P932

4067344

http://www.w3.org/2001/XMLSchema#string